Editorial: 365 days of progress in neuro-oncology and neurosurgical oncology

Front Oncol. 2023 Sep 7:13:1279957. doi: 10.3389/fonc.2023.1279957. eCollection 2023.

Erik P Sulman^{1

2

3

4}, David D Eisenstat^{1

5

6

7}

¹ Section of Neuro-oncology & Neurosurgical Oncology, Frontiers in Oncology and Frontiers in Neurology, Lausanne, Switzerland.
² Department of Radiation Oncology, NYU Grossman School of Medicine, New York, NY, United States.
³ Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center, New York, NY, United States.
⁴ NYU Langone Health, New York, NY, United States.
⁵ Children's Cancer Centre, Royal Children's Hospital, Parkville VIC, Australia.
⁶ Stem Cell Biology, Murdoch Children's Research Institute, Parkville, VIC, Australia.
⁷ Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.

No abstract available

Keywords: biomarker; brain tumor; palliative care; prognostic factor; tumor treating fields.

Publication types

DE is funded by an establishment grant from the Royal Children’s Hospital Foundation (2019-1193).